Concepedia

Author

Michael Brewster

Roche (United Kingdom)

Also Known As

M Brewster, M. Brewster, M. J. BREWSTER, M.J Brewster, M.J. Brewster, Michael Brewster

35

Publications

1.5K

Citations

19

H-Index

34

Concepts

All Affiliations

Roche (United Kingdom)Roche (Switzerland)St George HospitalRoche Pharma AG (Germany)Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
MB

About

Michael Brewster is an author at Roche (United Kingdom) specializing in medicine, nutrition, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

232

2

Education

4

4

472

3

Public Health

3

3

445

4

Health Sciences

2

2

69

5

Biochemistry

1

1

11

Michael Brewster

×

20

Publications

1.5K

Citations

19

H-Index

YearCitations

Lipid stability and meat colour of beef from pasture- and grain-fed cattle with or without vitamin E supplement

Aijun Yang, María Cecilia Lanari, Michael Brewster,

Meat Science

2002

222

Effect of vitamin E supplementation on α-tocopherol and β-carotene concentrations in tissues from pasture- and grain-fed cattle

Aijun Yang, Michael Brewster, María Cecilia Lanari,

Meat Science

2002

171

First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors

C. Willemien Menke‐van der Houven van Oordt, Carlos Gomez-Roca, Carla van Herpen,

Oncotarget

2016

148

Ro 32‐3555, an orally active collagenase inhibitor, prevents cartilage breakdown <i>in vitro</i> and <i>in vivo</i>

E. J. Lewis, Joshua D. Bishop, K M K Bottomley,

British Journal of Pharmacology

1997

135

Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial

Andrew Davies, Francesco Merli, Biljana Mihaljević,

The Lancet Haematology

2017

112

Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

Norbert Vey, Jacques Delaunay, Giovanni Martinelli,

Oncotarget

2016

94

Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis

Michael Brewster, Jonathan Lewis, Kevin L. Wilson,

Arthritis & Rheumatism

1998

82

Biological Properties of the Angiotensin-Converting Enzyme Inhibitor Cilazapril

Ian L. Natoff, John Nixon, Robert J. Francis,

Journal of Cardiovascular Pharmacology

1985

72

Geophysics and solvents: The Borden experiment

John P. Greenhouse, Michael Brewster, George W. Schneider,

The Leading Edge

1993

68

Pasture and Grain Finishing Affect the Color Stability of Beef

María Cecilia Lanari, Michael Brewster, Aijun Yang,

Journal of Food Science

2002

52

Page 1